Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-01-08

AUTHORS

K. Gert van Houwelingen, Liefke C. van der Heijden, Ming Kai Lam, Marlies M. Kok, Marije M. Löwik, J. W. Louwerenburg, Gerard C. M. Linssen, Maarten J. IJzerman, Carine J. M. Doggen, Clemens von Birgelen

ABSTRACT

The objective of this study is to assess 3-year clinical outcome of patients with true bifurcation lesions (TBLs) versus non-true bifurcation lesions (non-TBLs) following treatment with second-generation drug-eluting stents (DES). TBLs are characterized by the obstruction of both main vessel and side-branch. Limited data are available on long-term clinical outcome following TBL treatment with newer-generation DES. We performed an explorative sub-study of the randomized TWENTE trial among 287 patients who had bifurcated target lesions with side-branches ≥2.0 mm. Patients were categorized into TBL (Medina classes: 1.1.1; 1.0.1; 0.1.1) versus non-TBL to compare long-term clinical outcome. A total of 116 (40.4 %) patients had TBL, while 171 (59.6 %) had non-TBL only. Target-lesion revascularization rates were similar (3.5 vs. 3.5 %; p = 1.0), and definite-or-probable stent thrombosis rates were low (both <1.0 %). The target-vessel myocardial infarction (MI) rate was 11.3 versus 5.3 % (p = 0.06), mostly driven by (periprocedural) MI ≤48 h from PCI. All-cause mortality and cardiac death rates were 8.7 versus 3.5 % (p = 0.06) and 3.5 versus 1.2 % (p = 0.22), respectively. The 3-year major adverse cardiac event rate for patients with TBL versus non-TBL was 20.0 versus 11.7 % (p = 0.05). At 1-, 2-, and 3-year follow-up, 6.5, 13.0, and 11.0 % of patients reported chest pain at less than or equal moderate physical effort, respectively, without any between-group difference. Patients treated with second-generation DES for TBL had somewhat higher adverse event rates than patients with non-TBL, but dissimilarities did not reach statistical significance. Up to 3-year follow-up, the vast majority of patients of both groups remained free from chest pain. More... »

PAGES

1731-1739

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-015-0786-6

DOI

http://dx.doi.org/10.1007/s00380-015-0786-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030615612

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26747438


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1199", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Other Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angina Pectoris", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Angiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Artery Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Coronary Thrombosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Eluting Stents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Everolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardial Infarction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Percutaneous Coronary Intervention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prosthesis Design", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Houwelingen", 
        "givenName": "K. Gert", 
        "id": "sg:person.0722361045.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722361045.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van der Heijden", 
        "givenName": "Liefke C.", 
        "id": "sg:person.0611676220.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611676220.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lam", 
        "givenName": "Ming Kai", 
        "id": "sg:person.0632577224.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632577224.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kok", 
        "givenName": "Marlies M.", 
        "id": "sg:person.0660011420.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "L\u00f6wik", 
        "givenName": "Marije M.", 
        "id": "sg:person.01366106741.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366106741.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.415214.7", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Louwerenburg", 
        "givenName": "J. W.", 
        "id": "sg:person.01224017542.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224017542.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.417370.6", 
          "name": [
            "Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Linssen", 
        "givenName": "Gerard C. M.", 
        "id": "sg:person.012615570741.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012615570741.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Technology and Services Research, MIRA \u2013 Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Health Technology and Services Research, MIRA \u2013 Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "IJzerman", 
        "givenName": "Maarten J.", 
        "id": "sg:person.01310357224.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310357224.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Technology and Services Research, MIRA \u2013 Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Health Technology and Services Research, MIRA \u2013 Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Doggen", 
        "givenName": "Carine J. M.", 
        "id": "sg:person.01146757520.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Technology and Services Research, MIRA \u2013 Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands", 
          "id": "http://www.grid.ac/institutes/grid.6214.1", 
          "name": [
            "Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands", 
            "Health Technology and Services Research, MIRA \u2013 Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "von Birgelen", 
        "givenName": "Clemens", 
        "id": "sg:person.0600054325.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00380-014-0492-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030420850", 
          "https://doi.org/10.1007/s00380-014-0492-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00392-015-0907-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023203898", 
          "https://doi.org/10.1007/s00392-015-0907-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-012-0314-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018247521", 
          "https://doi.org/10.1007/s00380-012-0314-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00380-014-0611-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046909221", 
          "https://doi.org/10.1007/s00380-014-0611-7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-01-08", 
    "datePublishedReg": "2016-01-08", 
    "description": "The objective of this study is to assess 3-year clinical outcome of patients with true bifurcation lesions (TBLs) versus non-true bifurcation lesions (non-TBLs) following treatment with second-generation drug-eluting stents (DES). TBLs are characterized by the obstruction of both main vessel and side-branch. Limited data are available on long-term clinical outcome following TBL treatment with newer-generation DES. We performed an explorative sub-study of the randomized TWENTE trial among 287 patients who had bifurcated target lesions with side-branches \u22652.0\u00a0mm. Patients were categorized into TBL (Medina classes: 1.1.1; 1.0.1; 0.1.1) versus non-TBL to compare long-term clinical outcome. A total of 116 (40.4\u00a0%) patients had TBL, while 171 (59.6\u00a0%) had non-TBL only. Target-lesion revascularization rates were similar (3.5 vs. 3.5\u00a0%; p\u00a0=\u00a01.0), and definite-or-probable stent thrombosis rates were low (both <1.0\u00a0%). The target-vessel myocardial infarction (MI) rate was 11.3 versus 5.3\u00a0% (p\u00a0=\u00a00.06), mostly driven by (periprocedural) MI \u226448\u00a0h from PCI. All-cause mortality and cardiac death rates were 8.7 versus 3.5\u00a0% (p\u00a0=\u00a00.06) and 3.5 versus 1.2\u00a0% (p\u00a0=\u00a00.22), respectively. The 3-year major adverse cardiac event rate for patients with TBL versus non-TBL was 20.0 versus 11.7\u00a0% (p\u00a0=\u00a00.05). At 1-, 2-, and 3-year follow-up, 6.5, 13.0, and 11.0\u00a0% of patients reported chest pain at less than or equal moderate physical effort, respectively, without any between-group difference. Patients treated with second-generation DES for TBL had somewhat higher adverse event rates than patients with non-TBL, but dissimilarities did not reach statistical significance. Up to 3-year follow-up, the vast majority of patients of both groups remained free from chest pain.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00380-015-0786-6", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "keywords": [
      "second-generation drug-eluting stents", 
      "true bifurcation lesions", 
      "drug-eluting stents", 
      "non-true bifurcation lesions", 
      "long-term clinical outcomes", 
      "chest pain", 
      "clinical outcomes", 
      "bifurcation lesions", 
      "TWENTE trial", 
      "major adverse cardiac event rates", 
      "probable stent thrombosis rates", 
      "adverse cardiac event rates", 
      "new-generation drug-eluting stents", 
      "target lesion revascularization rate", 
      "event rates", 
      "higher adverse event rates", 
      "cardiac death rate", 
      "cardiac event rate", 
      "stent thrombosis rates", 
      "myocardial infarction rate", 
      "adverse event rates", 
      "long-term outcomes", 
      "moderate physical effort", 
      "revascularization rates", 
      "infarction rate", 
      "cause mortality", 
      "thrombosis rate", 
      "target lesions", 
      "patients", 
      "pain", 
      "lesions", 
      "death rate", 
      "statistical significance", 
      "group differences", 
      "main vessel", 
      "limited data", 
      "outcomes", 
      "stents", 
      "trials", 
      "treatment", 
      "physical effort", 
      "vast majority", 
      "obstruction", 
      "mortality", 
      "rate", 
      "PCI", 
      "total", 
      "vessels", 
      "MI", 
      "group", 
      "majority", 
      "differences", 
      "significance", 
      "study", 
      "objective", 
      "data", 
      "efforts", 
      "dissimilarity"
    ], 
    "name": "Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial", 
    "pagination": "1731-1739", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030615612"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-015-0786-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26747438"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-015-0786-6", 
      "https://app.dimensions.ai/details/publication/pub.1030615612"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_693.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00380-015-0786-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0786-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0786-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0786-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-015-0786-6'


 

This table displays all metadata directly associated to this object as RDF triples.

289 TRIPLES      21 PREDICATES      108 URIs      96 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-015-0786-6 schema:about N01498a295c624dfdb6e6aac10d2b3d36
2 N0f878174adb8472595a531d98f0cad10
3 N1520db0ed8ac4daaa44d221e9504ff36
4 N27f1684f61f64be585e2fd227b897eec
5 N383b8d39e55d4ca682790476f5d5889d
6 N3e7b04e3a0464048abf53053a455cded
7 N6a8ca4d96d9c463094019729e8adbdf3
8 N6b70a40f31f849e0a893870fcc5ba095
9 N7d528b593bac4a62a42c15857e41910e
10 N83551f1df483490abddbd4919ce2d163
11 N8e177106734d42c9923db8766562c1df
12 N8e4ef65691814382900550d9296bb448
13 N8f35d8f3198e4b9e81cf708d7fe96290
14 N9b25147dbaf244d5bd33bd1b36a1a2ff
15 Nadfeaabc0a2048b6bbf6b0ca67273ada
16 Nd2e22713d69d44599154405c99478576
17 Nd8598698b1b24e7a8de80a3290991ce9
18 Nd9473e0db71a4e06801e359da3c5564a
19 Nd97328f7cebf414a91c37cebe34dec2e
20 Ne33e58e40f0f45fa97f11d8003a298a1
21 Nf6d4564893484855aacb8bbe1de0dc2c
22 anzsrc-for:11
23 anzsrc-for:1199
24 schema:author Ne11e5154e97a4caa95b3629d9fb0b7f6
25 schema:citation sg:pub.10.1007/s00380-012-0314-x
26 sg:pub.10.1007/s00380-014-0492-9
27 sg:pub.10.1007/s00380-014-0611-7
28 sg:pub.10.1007/s00392-015-0907-3
29 schema:datePublished 2016-01-08
30 schema:datePublishedReg 2016-01-08
31 schema:description The objective of this study is to assess 3-year clinical outcome of patients with true bifurcation lesions (TBLs) versus non-true bifurcation lesions (non-TBLs) following treatment with second-generation drug-eluting stents (DES). TBLs are characterized by the obstruction of both main vessel and side-branch. Limited data are available on long-term clinical outcome following TBL treatment with newer-generation DES. We performed an explorative sub-study of the randomized TWENTE trial among 287 patients who had bifurcated target lesions with side-branches ≥2.0 mm. Patients were categorized into TBL (Medina classes: 1.1.1; 1.0.1; 0.1.1) versus non-TBL to compare long-term clinical outcome. A total of 116 (40.4 %) patients had TBL, while 171 (59.6 %) had non-TBL only. Target-lesion revascularization rates were similar (3.5 vs. 3.5 %; p = 1.0), and definite-or-probable stent thrombosis rates were low (both <1.0 %). The target-vessel myocardial infarction (MI) rate was 11.3 versus 5.3 % (p = 0.06), mostly driven by (periprocedural) MI ≤48 h from PCI. All-cause mortality and cardiac death rates were 8.7 versus 3.5 % (p = 0.06) and 3.5 versus 1.2 % (p = 0.22), respectively. The 3-year major adverse cardiac event rate for patients with TBL versus non-TBL was 20.0 versus 11.7 % (p = 0.05). At 1-, 2-, and 3-year follow-up, 6.5, 13.0, and 11.0 % of patients reported chest pain at less than or equal moderate physical effort, respectively, without any between-group difference. Patients treated with second-generation DES for TBL had somewhat higher adverse event rates than patients with non-TBL, but dissimilarities did not reach statistical significance. Up to 3-year follow-up, the vast majority of patients of both groups remained free from chest pain.
32 schema:genre article
33 schema:isAccessibleForFree true
34 schema:isPartOf N0919f496f69b4c86b8f8dbf30fea67e8
35 Nfb80bee1d9034dc1938ba4ef39de68f6
36 sg:journal.1095887
37 schema:keywords MI
38 PCI
39 TWENTE trial
40 adverse cardiac event rates
41 adverse event rates
42 bifurcation lesions
43 cardiac death rate
44 cardiac event rate
45 cause mortality
46 chest pain
47 clinical outcomes
48 data
49 death rate
50 differences
51 dissimilarity
52 drug-eluting stents
53 efforts
54 event rates
55 group
56 group differences
57 higher adverse event rates
58 infarction rate
59 lesions
60 limited data
61 long-term clinical outcomes
62 long-term outcomes
63 main vessel
64 major adverse cardiac event rates
65 majority
66 moderate physical effort
67 mortality
68 myocardial infarction rate
69 new-generation drug-eluting stents
70 non-true bifurcation lesions
71 objective
72 obstruction
73 outcomes
74 pain
75 patients
76 physical effort
77 probable stent thrombosis rates
78 rate
79 revascularization rates
80 second-generation drug-eluting stents
81 significance
82 statistical significance
83 stent thrombosis rates
84 stents
85 study
86 target lesion revascularization rate
87 target lesions
88 thrombosis rate
89 total
90 treatment
91 trials
92 true bifurcation lesions
93 vast majority
94 vessels
95 schema:name Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial
96 schema:pagination 1731-1739
97 schema:productId N5b6da32aad254586bd1a4d3984e7e236
98 N723629cff8054baa98648fe7f378b74c
99 Nfae92c36a0594684b37b55b77cdd60b3
100 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030615612
101 https://doi.org/10.1007/s00380-015-0786-6
102 schema:sdDatePublished 2022-08-04T17:04
103 schema:sdLicense https://scigraph.springernature.com/explorer/license/
104 schema:sdPublisher N9a3eee65962041dda5d773cefdfb564a
105 schema:url https://doi.org/10.1007/s00380-015-0786-6
106 sgo:license sg:explorer/license/
107 sgo:sdDataset articles
108 rdf:type schema:ScholarlyArticle
109 N01498a295c624dfdb6e6aac10d2b3d36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Humans
111 rdf:type schema:DefinedTerm
112 N0919f496f69b4c86b8f8dbf30fea67e8 schema:issueNumber 11
113 rdf:type schema:PublicationIssue
114 N0f878174adb8472595a531d98f0cad10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Drug-Eluting Stents
116 rdf:type schema:DefinedTerm
117 N1520db0ed8ac4daaa44d221e9504ff36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Middle Aged
119 rdf:type schema:DefinedTerm
120 N21addac3d37242e99425929a3718987e rdf:first sg:person.01146757520.17
121 rdf:rest Nfb19626cf501482491a573cc251e1150
122 N27f1684f61f64be585e2fd227b897eec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Disease-Free Survival
124 rdf:type schema:DefinedTerm
125 N285e8824fd8f432a826c7c9cff57ba4c rdf:first sg:person.01224017542.76
126 rdf:rest N2dc06280bca945bc8c02be147d610eb2
127 N2dc06280bca945bc8c02be147d610eb2 rdf:first sg:person.012615570741.59
128 rdf:rest Nea96f7545da8457da9d27e946eb52fcb
129 N383b8d39e55d4ca682790476f5d5889d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Coronary Angiography
131 rdf:type schema:DefinedTerm
132 N3e7b04e3a0464048abf53053a455cded schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Prosthesis Design
134 rdf:type schema:DefinedTerm
135 N5b6da32aad254586bd1a4d3984e7e236 schema:name doi
136 schema:value 10.1007/s00380-015-0786-6
137 rdf:type schema:PropertyValue
138 N6384dd3e3f954777ab46c49e12619bb0 rdf:first sg:person.0660011420.13
139 rdf:rest Nf1d08439fd27404fb2dcfc34322765e1
140 N6a8ca4d96d9c463094019729e8adbdf3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Myocardial Infarction
142 rdf:type schema:DefinedTerm
143 N6b70a40f31f849e0a893870fcc5ba095 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Kaplan-Meier Estimate
145 rdf:type schema:DefinedTerm
146 N6f4efeac3c344fd6872f96455790d435 rdf:first sg:person.0611676220.78
147 rdf:rest Nd3aa93f29c6d4d46967194711f8349d1
148 N723629cff8054baa98648fe7f378b74c schema:name dimensions_id
149 schema:value pub.1030615612
150 rdf:type schema:PropertyValue
151 N7d528b593bac4a62a42c15857e41910e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Aged
153 rdf:type schema:DefinedTerm
154 N83551f1df483490abddbd4919ce2d163 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Angina Pectoris
156 rdf:type schema:DefinedTerm
157 N8e177106734d42c9923db8766562c1df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Female
159 rdf:type schema:DefinedTerm
160 N8e4ef65691814382900550d9296bb448 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Risk Factors
162 rdf:type schema:DefinedTerm
163 N8f35d8f3198e4b9e81cf708d7fe96290 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Time Factors
165 rdf:type schema:DefinedTerm
166 N9a3eee65962041dda5d773cefdfb564a schema:name Springer Nature - SN SciGraph project
167 rdf:type schema:Organization
168 N9b25147dbaf244d5bd33bd1b36a1a2ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Sirolimus
170 rdf:type schema:DefinedTerm
171 Nadfeaabc0a2048b6bbf6b0ca67273ada schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Treatment Outcome
173 rdf:type schema:DefinedTerm
174 Nd2e22713d69d44599154405c99478576 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Percutaneous Coronary Intervention
176 rdf:type schema:DefinedTerm
177 Nd3aa93f29c6d4d46967194711f8349d1 rdf:first sg:person.0632577224.31
178 rdf:rest N6384dd3e3f954777ab46c49e12619bb0
179 Nd8598698b1b24e7a8de80a3290991ce9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Male
181 rdf:type schema:DefinedTerm
182 Nd9473e0db71a4e06801e359da3c5564a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Coronary Artery Disease
184 rdf:type schema:DefinedTerm
185 Nd97328f7cebf414a91c37cebe34dec2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Cardiovascular Agents
187 rdf:type schema:DefinedTerm
188 Ne11e5154e97a4caa95b3629d9fb0b7f6 rdf:first sg:person.0722361045.79
189 rdf:rest N6f4efeac3c344fd6872f96455790d435
190 Ne33e58e40f0f45fa97f11d8003a298a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
191 schema:name Everolimus
192 rdf:type schema:DefinedTerm
193 Nea96f7545da8457da9d27e946eb52fcb rdf:first sg:person.01310357224.29
194 rdf:rest N21addac3d37242e99425929a3718987e
195 Nf1d08439fd27404fb2dcfc34322765e1 rdf:first sg:person.01366106741.12
196 rdf:rest N285e8824fd8f432a826c7c9cff57ba4c
197 Nf6d4564893484855aacb8bbe1de0dc2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Coronary Thrombosis
199 rdf:type schema:DefinedTerm
200 Nfae92c36a0594684b37b55b77cdd60b3 schema:name pubmed_id
201 schema:value 26747438
202 rdf:type schema:PropertyValue
203 Nfb19626cf501482491a573cc251e1150 rdf:first sg:person.0600054325.83
204 rdf:rest rdf:nil
205 Nfb80bee1d9034dc1938ba4ef39de68f6 schema:volumeNumber 31
206 rdf:type schema:PublicationVolume
207 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
208 schema:name Medical and Health Sciences
209 rdf:type schema:DefinedTerm
210 anzsrc-for:1199 schema:inDefinedTermSet anzsrc-for:
211 schema:name Other Medical and Health Sciences
212 rdf:type schema:DefinedTerm
213 sg:journal.1095887 schema:issn 0910-8327
214 1615-2573
215 schema:name Heart and Vessels
216 schema:publisher Springer Nature
217 rdf:type schema:Periodical
218 sg:person.01146757520.17 schema:affiliation grid-institutes:grid.6214.1
219 schema:familyName Doggen
220 schema:givenName Carine J. M.
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146757520.17
222 rdf:type schema:Person
223 sg:person.01224017542.76 schema:affiliation grid-institutes:grid.415214.7
224 schema:familyName Louwerenburg
225 schema:givenName J. W.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01224017542.76
227 rdf:type schema:Person
228 sg:person.012615570741.59 schema:affiliation grid-institutes:grid.417370.6
229 schema:familyName Linssen
230 schema:givenName Gerard C. M.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012615570741.59
232 rdf:type schema:Person
233 sg:person.01310357224.29 schema:affiliation grid-institutes:grid.6214.1
234 schema:familyName IJzerman
235 schema:givenName Maarten J.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310357224.29
237 rdf:type schema:Person
238 sg:person.01366106741.12 schema:affiliation grid-institutes:grid.415214.7
239 schema:familyName Löwik
240 schema:givenName Marije M.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366106741.12
242 rdf:type schema:Person
243 sg:person.0600054325.83 schema:affiliation grid-institutes:grid.6214.1
244 schema:familyName von Birgelen
245 schema:givenName Clemens
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600054325.83
247 rdf:type schema:Person
248 sg:person.0611676220.78 schema:affiliation grid-institutes:grid.415214.7
249 schema:familyName van der Heijden
250 schema:givenName Liefke C.
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611676220.78
252 rdf:type schema:Person
253 sg:person.0632577224.31 schema:affiliation grid-institutes:grid.415214.7
254 schema:familyName Lam
255 schema:givenName Ming Kai
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632577224.31
257 rdf:type schema:Person
258 sg:person.0660011420.13 schema:affiliation grid-institutes:grid.415214.7
259 schema:familyName Kok
260 schema:givenName Marlies M.
261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660011420.13
262 rdf:type schema:Person
263 sg:person.0722361045.79 schema:affiliation grid-institutes:grid.415214.7
264 schema:familyName van Houwelingen
265 schema:givenName K. Gert
266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722361045.79
267 rdf:type schema:Person
268 sg:pub.10.1007/s00380-012-0314-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018247521
269 https://doi.org/10.1007/s00380-012-0314-x
270 rdf:type schema:CreativeWork
271 sg:pub.10.1007/s00380-014-0492-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030420850
272 https://doi.org/10.1007/s00380-014-0492-9
273 rdf:type schema:CreativeWork
274 sg:pub.10.1007/s00380-014-0611-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046909221
275 https://doi.org/10.1007/s00380-014-0611-7
276 rdf:type schema:CreativeWork
277 sg:pub.10.1007/s00392-015-0907-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023203898
278 https://doi.org/10.1007/s00392-015-0907-3
279 rdf:type schema:CreativeWork
280 grid-institutes:grid.415214.7 schema:alternateName Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands
281 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands
282 rdf:type schema:Organization
283 grid-institutes:grid.417370.6 schema:alternateName Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands
284 schema:name Department of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, The Netherlands
285 rdf:type schema:Organization
286 grid-institutes:grid.6214.1 schema:alternateName Health Technology and Services Research, MIRA – Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands
287 schema:name Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Haaksbergerstraat 55, 7513 ER, Enschede, The Netherlands
288 Health Technology and Services Research, MIRA – Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands
289 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...